Press Releases - 2020

Download the PDF version
2020-12-17MMMM DD YYYY
Press releases
Availability of the Q4 2020 Memorandum for modelling purposes
Download the PDF version
2020-12-15MMMM DD YYYY
Press releases
Sanofi renews partnership with the WHO to fight Neglected Tropical Diseases and eliminate sleeping sickness before 2030
Download the PDF version
2020-12-11MMMM DD YYYY
Press releases
CHMP recommends approval of Plavix® (clopidogrel) with aspirin in adults for certain types of strokes
Download the PDF version
2020-12-11MMMM DD YYYY
Press releases
Sanofi and GSK announce a delay in their adjuvanted recombinant protein-based COVID-19 vaccine program to improve immune response in the elderly
Download the PDF version
2020-12-10MMMM DD YYYY
Press releases
Sanofi to resume dosing in fitusiran clinical studies in the U.S.
Download the PDF version
2020-12-09MMMM DD YYYY
Press releases
Sanofi pioneers sustainable finance in the pharmaceutical industry with the signing of its two first sustainability-linked revolving credit facilities
Download the PDF version
2020-12-09MMMM DD YYYY
Press releases
Sanofi and Kiadis satisfy competition condition related to the tender offer
Download the PDF version
2020-11-30MMMM DD YYYY
Press releases
Dupixent® (dupilumab) approved by European Commission as first and only biologic medicine for children aged 6 to 11 years with severe atopic dermatitis
Download the PDF version
2020-11-30MMMM DD YYYY
Press releases
Update on the intended offer by Sanofi for Kiadis
Download the PDF version
2020-11-23MMMM DD YYYY
Press releases
European Commission approves MenQuadfi®, the latest innovation in meningococcal (MenACWY) vaccination for individuals 12 months of age and older
Download the PDF version
2020-11-18MMMM DD YYYY
Press releases
European Commission approves Supemtek® (quadrivalent recombinant influenza vaccine) for the prevention of influenza in adults aged 18 years and older
Download the PDF version
2020-11-18MMMM DD YYYY
Press releases
Rilzabrutinib granted FDA Fast Track Designation for treatment of immune thrombocytopenia
Download the PDF version
2020-11-18MMMM DD YYYY
Press releases
FDA grants priority review for avalglucosidase alfa, a potential new therapy for Pompe disease
Download the PDF version
2020-11-14MMMM DD YYYY
Press releases
FDA issues Complete Response Letter for sutimlimab, an investigational treatment for hemolysis in adults with cold agglutinin disease
Download the PDF version
2020-11-05MMMM DD YYYY
Press releases
New clinical and health-related quality of life data in multiple myeloma and rare blood disorders to be presented at ASH 2020
Download the PDF version
2020-11-02MMMM DD YYYY
Press releases
Sanofi offers to acquire Kiadis, a clinical-stage company developing cell-based immunotherapy products
Download the PDF version
2020-11-02MMMM DD YYYY
Press releases
Sanofi offers to acquire Kiadis for €308 million
Download the PDF version
2020-10-29MMMM DD YYYY
Press releases
European Patent Office rules in favor of Sanofi and Regeneron concerning Praluent® (alirocumab)
Download the PDF version
2020-10-29MMMM DD YYYY
Press releases
Sanofi Q3 2020 business EPS(1) growth of 8.8% at CER
Download the PDF version
2020-10-29MMMM DD YYYY
Press releases
Safety and efficacy of Dupixent® (dupilumab) in patients as young as 6 years with moderate-to-severe atopic dermatitis further reinforced by new data analyses presented at EADV
Download the PDF version
2020-10-29MMMM DD YYYY
Press releases
Sanofi to evaluate the safety and efficacy of novel investigational candidate THOR-707 and KEYTRUDA® (pembrolizumab) in pursuit of establishing a new treatment option in oncology
Download the PDF version
2020-10-28MMMM DD YYYY
Press releases
Sanofi and GSK to support COVAX with 200 million doses of adjuvanted, recombinant protein-based COVID-19 vaccine
Download the PDF version
2020-10-26MMMM DD YYYY
Press releases
Dupixent® (dupilumab) late-breaking pivotal data showing significant improvement in eosinophilic esophagitis signs and symptoms presented for the first time at scientific meetings
Download the PDF version
2020-10-16MMMM DD YYYY
Press releases
CHMP recommends approval of Dupixent® (dupilumab) for children aged 6 to 11 years with severe atopic dermatitis
Download the PDF version
2020-10-15MMMM DD YYYY
Press releases
Sanofi and Translate Bio mRNA COVID-19 vaccine candidate induced high antibody levels in preclinical studies
Download the PDF version
2020-10-13MMMM DD YYYY
Press releases
Dupixent® (dupilumab) significantly reduced severe asthma attacks in children and is the only biologic to demonstrate improvement in children’s lung function in a randomized Phase 3 trial
Download the PDF version
2020-10-02MMMM DD YYYY
Press releases
EMA accepts regulatory submission for avalglucosidase alfa, a potentially new standard of care enzyme replacement therapy for Pompe disease
Download the PDF version
2020-09-28MMMM DD YYYY
Press releases
Sanofi completes Principia Biopharma Inc. acquisition
Download the PDF version
2020-09-25MMMM DD YYYY
Press releases
Availability of the Q3 2020 Memorandum for modelling purposes
Download the PDF version
2020-09-22MMMM DD YYYY
Press releases
CHMP recommends approval of Supemtek® (quadrivalent recombinant influenza vaccine) for the prevention of influenza in adults aged 18 years and older
Download the PDF version
2020-09-22MMMM DD YYYY
Press releases
Sanofi and GSK sign agreements with the Government of Canada to supply up to 72 million doses of adjuvanted COVID-19 vaccine
Download the PDF version
2020-09-22MMMM DD YYYY
Press releases
CHMP recommends approval of MenQuadfi® for active immunization of individuals from the age of 12 months and older against invasive meningococcal ACWY disease
Download the PDF version
2020-09-22MMMM DD YYYY
Press releases
Hart-Scott-Rodino waiting period expires for Sanofi’s acquisition of Principia Biopharma Inc.
Download the PDF version
2020-09-21MMMM DD YYYY
Press releases
Late-breaking ESMO presentation shows Libtayo® (cemiplimab) monotherapy increases overall survival in first-line advanced non-small cell lung cancer with PD-L1 expression of ≥50%
Download the PDF version
2020-09-18MMMM DD YYYY
Press releases
Sanofi and GSK will provide up to 300 million doses of COVID-19 vaccine to the European Union
Download the PDF version
2020-09-18MMMM DD YYYY
Press releases
Positive pivotal data for Libtayo® (cemiplimab) monotherapy in locally advanced basal cell carcinoma featured as a late-breaking presentation at ESMO
Download the PDF version
2020-09-18MMMM DD YYYY
Press releases
Dr. Jean-Christophe Rufin appointed President of the Sanofi Espoir Corporate Foundation
Download the PDF version
2020-09-14MMMM DD YYYY
Press releases
FDA grants Dupixent® (dupilumab) Breakthrough Therapy designation for eosinophilic esophagitis
Download the PDF version
2020-09-10MMMM DD YYYY
Press releases
New England Journal of Medicine publishes positive final results from Phase 1/2a study of BIVV001 in people with severe hemophilia A
Download the PDF version
2020-09-08MMMM DD YYYY
Press releases
Dupixent® (dupilumab) long-term data show sustained improvement in lung function and reduction in severe exacerbations in adults and adolescents with moderate-to-severe asthma
Download the PDF version
2020-09-03MMMM DD YYYY
Press releases
Sanofi and GSK initiate Phase 1/2 clinical trial of COVID-19 adjuvanted recombinant protein-based vaccine candidate
Download the PDF version
2020-09-01MMMM DD YYYY
Press releases
Sanofi provides update on Kevzara® (sarilumab) Phase 3 trial in severe and critically ill COVID-19 patients outside the U.S.
Download the PDF version
2020-08-28MMMM DD YYYY
Press releases
Sanofi to commence tender offer for acquisition of Principia Biopharma Inc.
Download the PDF version
2020-08-17MMMM DD YYYY
Press releases
Sanofi to acquire Principia Biopharma
Download the PDF version
2020-07-31MMMM DD YYYY
Press releases
Sanofi and GSK in advanced discussions with European Union to supply up to 300 million doses of COVID-19 vaccine
Download the PDF version
2020-07-31MMMM DD YYYY
Press releases
Sanofi and GSK selected for Operation Warp Speed to supply United States government with 100 million doses of COVID-19 vaccine
SanofiNirsevimab NEJM Global ReleaseFINAL RELEASED
2020-07-30MMMM DD YYYY
Press releases
Nirsevimab reduced respiratory syncytial virus infections requiring medical care in healthy premature infants in Phase 2b trial
Download the PDF version
2020-07-29MMMM DD YYYY
Press releases
Online availability of Sanofi’s half-year financial report for 2020
2020_07_29_Q2_2020_PR_EN_v3
2020-07-29MMMM DD YYYY
Press releases
Sanofi H1 2020 business EPS(1) growth of 9.2%(2) driven by transformation
Download the PDF version
2020-07-29MMMM DD YYYY
Press releases
Sanofi and GSK agree with the UK government to supply up to 60 million doses of COVID-19 vaccine
Download the PDF version
2020-07-06MMMM DD YYYY
Press releases
Availability of the Pre-quarterly Results Communication
Download the PDF version
2020-07-02MMMM DD YYYY
Press releases
Sanofi and Regeneron provide update on Kevzara® (sarilumab) Phase 3 U.S. trial in COVID-19 patients
Download the PDF version
2020-06-23MMMM DD YYYY
Press releases
Sanofi’s virtual R&D Day event to highlight capabilities, platforms, and expertise in disease pathways to deliver potentially transformative treatments to patients
Download the PDF version
2020-06-23MMMM DD YYYY
Press releases
Sanofi and Translate Bio expand collaboration to develop mRNA vaccines across all infectious disease areas
Download the PDF version
2020-06-19MMMM DD YYYY
Press releases
Sanofi announces positive long-term efficacy and safety data for fitusiran from interim analysis of Phase 2 extension study in people with hemophilia A and B, with or without inhibitors
Download the PDF version
2020-06-19MMMM DD YYYY
Press releases
Dupixent® (dupilumab) approved in China for adults with moderate-to-severe atopic dermatitis
Download the PDF version
2020-06-16MMMM DD YYYY
Press releases
Sanofi’s investigational enzyme replacement therapy shows clinically meaningful improvement in critical manifestations of late-onset Pompe disease
Download the PDF version
2020-06-16MMMM DD YYYY
Press releases
Sanofi invests to make France its world class center of excellence in vaccine research and production
Dupixent event PR-ENG
2020-06-11MMMM DD YYYY
Press releases
Sanofi to present growth opportunities and development strategy for Dupixent® (dupilumab) in type 2 inflammatory diseases
Download the PDF version
2020-06-08MMMM DD YYYY
Press releases
Sanofi to present Phase 3 results of avalglucosidase alfa in patients with late-onset Pompe disease
Download the PDF version
2020-06-03MMMM DD YYYY
Press releases
Sanofi to launch “Action 2020”, a worldwide employee stock purchase plan
Download the PDF version
2020-06-02MMMM DD YYYY
Press releases
Sarclisa® (isatuximab) combination therapy demonstrated superior progression free survival and clinically meaningful depth of response in patients with relapsed multiple myeloma
Download the PDF version
2020-06-02MMMM DD YYYY
Press releases
European Commission approves Sarclisa® (isatuximab) for adults with relapsed and refractory multiple myeloma
200602-GPR-oncology-event-EN
2020-06-02MMMM DD YYYY
Press releases
Sanofi to present oncology strategy, provide update on portfolio and emerging pipeline
Download the PDF version
2020-05-29MMMM DD YYYY
Press releases
Sanofi announces closing of Regeneron stock sale
Download the PDF version
2020-05-29MMMM DD YYYY
Press releases
Libtayo® (cemiplimab-rwlc) longer-term results in advanced cutaneous squamous cell carcinoma presented at ASCO 2020 show durable responses that deepen over time
Download the PDF version
2020-05-29MMMM DD YYYY
Press releases
Sanofi names new leaders to Executive Committee
Press-Release-20200528
2020-05-28MMMM DD YYYY
Press releases
Sanofi’s Board of Directors notes the resignation of Emmanuel Babeau and coopts Gilles Schnepp as Independent Director
Download the PDF version
2020-05-27MMMM DD YYYY
Press releases
Sanofi announces pricing of Regeneron stock offering
Download the PDF version
2020-05-26MMMM DD YYYY
Press releases
Sanofi: FDA approves Dupixent® (dupilumab) as first biologic medicine for children aged 6 to 11 years with moderate-to-severe atopic dermatitis
Download the PDF version
2020-05-25MMMM DD YYYY
Press releases
Sanofi intends to sell its equity investment in Regeneron; confirms no change to ongoing collaboration
Download the PDF version
2020-05-23MMMM DD YYYY
Press releases
Dupixent® (dupilumab) eosinophilic esophagitis trial meets both co-primary endpoints
Download the PDF version
2020-05-18MMMM DD YYYY
Press releases
Sanofi to highlight pipeline programs in a series of interactive virtual sessions leading to a R&D day event
Download the PDF version
2020-05-14MMMM DD YYYY
Press releases
FDA grants priority review of sutimlimab, potential first approved treatment of hemolysis in adult patients with Cold Agglutinin Disease
Download the PDF version
2020-05-12MMMM DD YYYY
Press releases
Sarclisa® (isatuximab) Phase 3 IKEMA trial meets primary endpoint early in patients with relapsed multiple myeloma
Download the PDF version
2020-05-05MMMM DD YYYY
Press releases
Libtayo® (cemiplimab) shows clinically meaningful and durable responses in second-line advanced basal cell carcinoma
Download the PDF version
2020-04-28MMMM DD YYYY
Press releases
Sanofi: Annual General Meeting of April 28, 2020
Download the PDF version
2020-04-27MMMM DD YYYY
Press releases
Sanofi: Phase 3 trial of Libtayo® (cemiplimab) as monotherapy for first-line advanced non-small cell lung cancer stopped early due to highly significant improvement in overall survival
Download the PDF version
2020-04-27MMMM DD YYYY
Press releases
Sanofi and Regeneron provide update on U.S. Phase 2/3 adaptive-designed trial in hospitalized COVID-19 patients
Download the PDF version
2020-04-24MMMM DD YYYY
Press releases
Sanofi at forefront of fight against COVID-19 in Q1 2020
Download the PDF version
2020-04-24MMMM DD YYYY
Press releases
FDA approves MenQuadfiTM, the latest innovation in meningococcal (MenACWY) vaccination
Download the PDF version
2020-04-23MMMM DD YYYY
Press releases
Sanofi brain-penetrant BTK inhibitor significantly reduced disease activity in Phase 2 trial in relapsing multiple sclerosis
Download the PDF version
2020-04-17MMMM DD YYYY
Press releases
Sanofi to present Phase 2 detailed results of its brain-penetrant BTK inhibitor in relapsing multiple sclerosis
Download the PDF version
2020-04-16MMMM DD YYYY
Press releases
Sanofi and Luminostics to join forces on developing breakthrough COVID-19 smartphone-based self-testing solution
Sanofi and GSK to join forces in unprecedented collaboration to fight COVID-19 ENG
2020-04-14MMMM DD YYYY
Press releases
Sanofi and GSK to join forces in unprecedented vaccine collaboration to fight COVID-19
Download the PDF version
2020-04-10MMMM DD YYYY
Press releases
COVID-19: Sanofi to donate 100 million doses of hydroxychloroquine across 50 countries
Download the PDF version
2020-04-06MMMM DD YYYY
Press releases
Sanofi finalizes Praluent® (alirocumab) restructuring with Regeneron
Download the PDF version
2020-04-06MMMM DD YYYY
Press releases
Sanofi successfully prices taps on outstanding bond issues for EUR 500 million
Download the PDF version
2020-04-03MMMM DD YYYY
Press releases
Sanofi: Availability of the Pre-quarterly Results Communication
Download the PDF version
2020-04-03MMMM DD YYYY
Press releases
Sanofi: Dupixent® (dupilumab) Phase 3 data show significant improvement in severe atopic dermatitis for children aged 6 to 11 years
Download the PDF version
2020-04-01MMMM DD YYYY
Press releases
Sanofi: Information on Sanofi’s Shareholder General Meeting of Tuesday, April 28, 2020
Download the PDF version
2020-03-30MMMM DD YYYY
Press releases
Sanofi: First patient outside U.S. treated in global Kevzara® (sarilumab) clinical trial program for patients with severe COVID-19
Download the PDF version
2020-03-27MMMM DD YYYY
Press releases
Sanofi receives positive CHMP opinion for Sarclisa® (isatuximab) for the treatment of relapsed and refractory multiple myeloma
Download the PDF version
2020-03-27MMMM DD YYYY
Press releases
Sanofi and Translate Bio collaborate to develop novel mRNA vaccine candidate against COVID-19
Download the PDF version
2020-03-24MMMM DD YYYY
Press releases
Sanofi successfully prices EUR 1.5 billion of bond issue
Download the PDF version
2020-03-05MMMM DD YYYY
Press releases
Sanofi : Filing of the 2019 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report
Download the PDF version
2020-03-04MMMM DD YYYY
Press releases
Sanofi's Board of Directors proposes the appointment of Rachel Duan and Lise Kingo as independent directors
Download the PDF version
2020-03-02MMMM DD YYYY
Press releases
Sanofi : FDA approves Sarclisa® (isatuximab-irfc) for patients with relapsed refractory multiple myeloma
Download the PDF version
2020-02-24MMMM DD YYYY
Press releases
Sanofi to create new industry leading European company to provide active pharmaceutical ingredients (API*)
Download the PDF version
2020-02-18MMMM DD YYYY
Press releases
Sanofi joins forces with U.S. Department of Health and Human Services to advance a novel coronavirus vaccine
2019_Q4_Press_Release_v2_EN
2020-02-06MMMM DD YYYY
Press releases
Sanofi delivers strong 2019 business EPS growth of 6.8% at CER
Download the PDF version
2020-02-06MMMM DD YYYY
Press releases
Sanofi : Sanofi brain-penetrant BTK inhibitor meets primary endpoint of Phase 2 trial in relapsing multiple sclerosis
Download the PDF version
2020-01-30MMMM DD YYYY
Press releases
Sanofi : Positive topline results demonstrated by olipudase alfa, first and only investigational therapy in late-stage development for acid sphingomyelinase deficiency
Download the PDF version
2020-01-28MMMM DD YYYY
Press releases
Sanofi : FDA accepts for priority review Dupixent® (dupilumab) for children aged 6 to 11 years with moderate-to-severe atopic dermatitis
Download the PDF version
2020-01-23MMMM DD YYYY
Press releases
Sanofi : Sanofi Completes Acquisition of Synthorx, Inc.
Download the PDF version
2020-01-20MMMM DD YYYY
Press releases
Sanofi : Hart-Scott-Rodino waiting period expires for Sanofi’s acquisition of Synthorx
Download the PDF version
2020-01-09MMMM DD YYYY
Press releases
Sanofi : Availability of the Pre-quarterly Results Communication

Press Releases 2020

Press Releases - 2020

Follow us